Market Scorecard
Market Pathways Scorecard: Q1 FDA Authorizations
A graphical look at FDA novel device approvals, 510(k)s, and PMA supplements during the first quarter of 2026.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Business Strategies
Biologically Focused Development Increases Success
On a panel at the annual Dublin Innovation Summit engaged stakeholders discuss the benefits and challenges of gathering deep data during the development and testing of therapies and diagnostics, specific to the gender of the patients who will benefit from the medical interventions.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Pathways’ Pick of the Week
Pathway's Pick of the Week: Europe’s Breakthroughs
The EU has launched its pilot breakthrough program. Excerpted from Pathways’ Picks May 8: Notified Body Rules, EU Breakthroughs, China Exemptions, and More.